Cite
Hamajima K, Hamamura K, Chen A, et al. Suppression of osteoclastogenesis via α2-adrenergic receptors. Biomed Rep. 2018;8(5):407-416doi: 10.3892/br.2018.1075.
Hamajima, K., Hamamura, K., Chen, A., Yokota, H., Mori, H., Yo, S., Kondo, H., Tanaka, K., Ishizuka, K., Kodama, D., Hirai, T., Miyazawa, K., Goto, S., & Togari, A. (2018). Suppression of osteoclastogenesis via α2-adrenergic receptors. Biomedical reports, 8(5), 407-416. https://doi.org/10.3892/br.2018.1075
Hamajima, Kosuke, et al. "Suppression of osteoclastogenesis via α2-adrenergic receptors." Biomedical reports vol. 8,5 (2018): 407-416. doi: https://doi.org/10.3892/br.2018.1075
Hamajima K, Hamamura K, Chen A, Yokota H, Mori H, Yo S, Kondo H, Tanaka K, Ishizuka K, Kodama D, Hirai T, Miyazawa K, Goto S, Togari A. Suppression of osteoclastogenesis via α2-adrenergic receptors. Biomed Rep. 2018 May;8(5):407-416. doi: 10.3892/br.2018.1075. Epub 2018 Mar 09. PMID: 29725523; PMCID: PMC5920467.
Copy
Download .nbib